174 related articles for article (PubMed ID: 26642307)
1. Functional imaging of interstitial brachytherapy in pancreatic carcinoma xenografts using spectral CT: how does iodine concentration correlate with standardized uptake value of (18)FDG-PET-CT?
Hu S; Shi X; Chen Y; Huang W; Song Q; Lin X; Liu Y; Chen K; Wang Z
Br J Radiol; 2016; 89(1058):20150573. PubMed ID: 26642307
[TBL] [Abstract][Full Text] [Related]
2. Spectral CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts: preliminary animal experience.
Hu S; Huang W; Chen Y; Song Q; Lin X; Wang Z; Chen K
Eur Radiol; 2014 Sep; 24(9):2167-73. PubMed ID: 24903229
[TBL] [Abstract][Full Text] [Related]
3. MicroPET-CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts.
Jian L; Zhongmin W; Kemin C; Yunfeng Z; Gang H
Acta Radiol; 2013 Sep; 54(7):800-4. PubMed ID: 23612430
[TBL] [Abstract][Full Text] [Related]
4. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Liu Y; Liu M; Liu X; Zhou Y
Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Iodine-125 Interstitial Brachytherapy Using Micro-Positron Emission Tomography/Computed Tomography with 18F-Fluorodeoxyglucose in Hepatocellular Carcinoma HepG2 Xenografts.
Zhu Y; Dong M; Yang J; Zhang J
Med Sci Monit; 2019 Jan; 25():371-380. PubMed ID: 30636171
[TBL] [Abstract][Full Text] [Related]
6. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
7. Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG.
Zhao C; Chen Z; Ye X; Zhang Y; Zhan H; Aburano T; Tian M; Zhang H
Nucl Med Commun; 2009 Dec; 30(12):971-7. PubMed ID: 19696689
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors.
Kawada N; Uehara H; Hosoki T; Takami M; Shiroeda H; Arisawa T; Tomita Y
Pancreas; 2015 May; 44(4):655-9. PubMed ID: 25815646
[TBL] [Abstract][Full Text] [Related]
9. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
10.
Su W; Zhao S; Chen Y; Zuo C; Cui B; Wang M; Ren F
Abdom Radiol (NY); 2020 Mar; 45(3):743-749. PubMed ID: 31907569
[TBL] [Abstract][Full Text] [Related]
11. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
13. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
14. 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis.
Chatziioannou S; Papamichos O; Gamaletsou MN; Georgakopoulos A; Kostomitsopoulos NG; Tseleni-Balafouta S; Papaparaskevas J; Walsh TJ; Pneumaticos SG; Sipsas NV
J Orthop Surg Res; 2015 Aug; 10():132. PubMed ID: 26306506
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of maximum standardized uptake value (SUVmax) on 18F-FDG PET/CT in patients with locally advanced or metastatic pancreatic cancer.
Moon SY; Joo KR; So YR; Lim JU; Cha JM; Shin HP; Yang YJ
Clin Nucl Med; 2013 Oct; 38(10):778-83. PubMed ID: 24107806
[TBL] [Abstract][Full Text] [Related]
16. Dual-Layer Spectral Detector CT in Comparison with FDG-PET/CT for the Assessment of Lymphoma Activity.
Gehling K; Mokry T; Do TD; Giesel FL; Dietrich S; Haberkorn U; Kauczor HU; Weber TF
Rofo; 2022 Jul; 194(7):747-754. PubMed ID: 35211927
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of pancreatic cancer using ¹⁸F-FDG PET/CT and CA19-9 with SUVmax association to clinical characteristics.
Sun Y; Duan Q; Wang S; Zeng Y; Wu R
J BUON; 2015; 20(2):452-9. PubMed ID: 26011335
[TBL] [Abstract][Full Text] [Related]
18. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
[TBL] [Abstract][Full Text] [Related]
19. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
